BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20392097)

  • 1. An alternative synthesis of 1,1'-bis-valienamine from D-glucose.
    Shing TK; Cheng HM
    J Org Chem; 2010 May; 75(10):3522-5. PubMed ID: 20392097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
    Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the synthesis of valienamine and 1-epi-valienamine starting from D-glucose or L-sorbose.
    Cumpstey I; Gehrke S; Erfan S; Cribiu R
    Carbohydr Res; 2008 Jul; 343(10-11):1675-92. PubMed ID: 18468588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flexible strategy based on a C2-symmetric pool of chiral substrates: concise synthesis of (+)-valienamine, key intermediate of (+)- pancratistatin, and conduramines A-1 and E.
    Chang YK; Lo HJ; Yan TH
    Org Lett; 2009 Oct; 11(19):4278-81. PubMed ID: 19711969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient synthesis of valienamine via ring-closing metathesis.
    Chang YK; Lee BY; Kim DJ; Lee GS; Jeon HB; Kim KS
    J Org Chem; 2005 Apr; 70(8):3299-302. PubMed ID: 15823000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
    Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
    Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel synthesis of natural pseudo-aminosugars, (+)-valienamine and (+)-validamine.
    Tatsuta K; Mukai H; Takahashi M
    J Antibiot (Tokyo); 2000 Apr; 53(4):430-5. PubMed ID: 10866227
    [No Abstract]   [Full Text] [Related]  

  • 8. A 1-acetamido derivative of 6-epi-valienamine: an inhibitor of a diverse group of beta-N-acetylglucosaminidases.
    Scaffidi A; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Vocadlo DJ; Stick RV
    Org Biomol Chem; 2007 Sep; 5(18):3013-9. PubMed ID: 17728868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new synthesis of valienamine.
    Kok SH; Lee CC; Shing TK
    J Org Chem; 2001 Oct; 66(21):7184-90. PubMed ID: 11597249
    [No Abstract]   [Full Text] [Related]  

  • 10. A new pre-column derivatization for valienamine and beta-valienamine using o-phthalaldehyde to determine the epimeric purity by HPLC and application of this method to monitor enzymatic catalyzed synthesis of beta-valienamine.
    Cui L; Guan XQ; Liu ZM; Fan LY; Li Q; Feng Y
    J Asian Nat Prod Res; 2017 Apr; 19(4):347-357. PubMed ID: 28367638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile, efficient, and enantiospecific syntheses of 1,1'-N-linked pseudodisaccharides as a new class of glycosidase inhibitors.
    Shing TK; Kwong CS; Cheung AW; Kok SH; Yu Z; Li J; Cheng CH
    J Am Chem Soc; 2004 Dec; 126(49):15990-2. PubMed ID: 15584732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinylogy in orthoester hydrolysis: total syntheses of cyclophellitol, valienamine, gabosine K, valienone, gabosine G, 1-epi-streptol, streptol, and uvamalol A.
    Mondal S; Prathap A; Sureshan KM
    J Org Chem; 2013 Aug; 78(15):7690-700. PubMed ID: 23879653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S.
    Si A; Jayasinghe TD; Thanvi R; Kapil S; Ronning DR; Sucheck SJ
    Sci Rep; 2021 Jun; 11(1):13413. PubMed ID: 34183716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical synthesis of a gamma-secretase inhibitor.
    Scott JP; Lieberman DR; Beureux OM; Brands KM; Davies AJ; Gibson AW; Hammond DC; McWilliams CJ; Stewart GW; Wilson RD; Dolling UH
    J Org Chem; 2007 May; 72(11):4149-55. PubMed ID: 17465573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
    Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
    Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and activities as trehalase inhibitors of N-arylglycosylamines derived from fluorinated anilines.
    Qian X; Li Z; Liu Z; Song G; Li Z
    Carbohydr Res; 2001 Nov; 336(1):79-82. PubMed ID: 11675029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and production of valienamine and its related analogues.
    Chen X; Fan Y; Zheng Y; Shen Y
    Chem Rev; 2003 May; 103(5):1955-77. PubMed ID: 12744697
    [No Abstract]   [Full Text] [Related]  

  • 18. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
    Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
    Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereodivergent syntheses of conduramines and aminocyclitols.
    Alegret C; Benet-Buchholz J; Riera A
    Org Lett; 2006 Jul; 8(14):3069-72. PubMed ID: 16805554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formal total synthesis of the potent renin inhibitor aliskiren: application of a SmI2-promoted acyl-like radical coupling.
    Lindsay KB; Skrydstrup T
    J Org Chem; 2006 Jun; 71(13):4766-77. PubMed ID: 16776501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.